-DOCSTART- -X- O
Among -X- _ O
approximately -X- _ O
1000 -X- _ O
adenoviruses -X- _ O
from -X- _ O
chimpanzees -X- _ O
and -X- _ O
bonobos -X- _ O
studied -X- _ O
recently -X- _ O
, -X- _ O
the -X- _ O
Pan -X- _ B-Intervention
Adenovirus -X- _ I-Intervention
type -X- _ I-Intervention
3 -X- _ I-Intervention
( -X- _ I-Intervention
PanAd3 -X- _ I-Intervention
, -X- _ I-Intervention
isolated -X- _ I-Intervention
from -X- _ I-Intervention
a -X- _ I-Intervention
bonobo -X- _ I-Intervention
, -X- _ I-Intervention
Pan -X- _ I-Intervention
paniscus -X- _ I-Intervention
) -X- _ I-Intervention
has -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
best -X- _ O
profiles -X- _ O
for -X- _ O
a -X- _ O
vaccine -X- _ O
vector -X- _ O
, -X- _ O
combining -X- _ O
potent -X- _ O
transgene -X- _ O
immunogenicity -X- _ O
with -X- _ O
minimal -X- _ O
pre- -X- _ O
existing -X- _ O
immunity -X- _ O
in -X- _ O
the -X- _ O
human -X- _ O
population. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
inserted -X- _ O
into -X- _ O
a -X- _ O
replication -X- _ O
defective -X- _ O
PanAd3 -X- _ B-Intervention
a -X- _ I-Intervention
transgene -X- _ I-Intervention
expressing -X- _ I-Intervention
a -X- _ I-Intervention
fusion -X- _ I-Intervention
protein -X- _ I-Intervention
of -X- _ I-Intervention
conserved -X- _ I-Intervention
influenza -X- _ I-Intervention
antigens -X- _ I-Intervention
nucleoprotein -X- _ I-Intervention
( -X- _ I-Intervention
NP -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
matrix -X- _ I-Intervention
1 -X- _ I-Intervention
( -X- _ I-Intervention
M1 -X- _ I-Intervention
) -X- _ I-Intervention
. -X- _ O
We -X- _ O
then -X- _ O
studied -X- _ O
antibody -X- _ O
and -X- _ O
T -X- _ O
cell -X- _ O
responses -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
protection -X- _ O
from -X- _ O
challenge -X- _ O
infection -X- _ O
in -X- _ O
a -X- _ O
mouse -X- _ B-Patient
model. -X- _ I-Patient
A -X- _ O
single -X- _ B-Outcome
intranasal -X- _ I-Outcome
administration -X- _ I-Outcome
of -X- _ I-Outcome
PanAd3-NPM1 -X- _ I-Outcome
vaccine -X- _ I-Outcome
induced -X- _ I-Outcome
strong -X- _ I-Outcome
antibody -X- _ I-Outcome
and -X- _ I-Outcome
T -X- _ I-Outcome
cell -X- _ I-Outcome
responses -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
protected -X- _ I-Outcome
against -X- _ I-Outcome
high -X- _ I-Outcome
dose -X- _ I-Outcome
lethal -X- _ I-Outcome
influenza -X- _ I-Outcome
virus -X- _ I-Outcome
challenge. -X- _ I-Outcome
Thus -X- _ O
PanAd3 -X- _ O
is -X- _ O
a -X- _ O
promising -X- _ O
candidate -X- _ O
vector -X- _ O
for -X- _ O
vaccines -X- _ O
, -X- _ O
including -X- _ O
universal -X- _ O
influenza -X- _ O
vaccines -X- _ O
. -X- _ O

